Core Viewpoint - The event highlighted the importance of rigorous processes and assessment mechanisms in selecting and managing research partners for drug development [1] Group 1: Company Overview - Hongri Pharmaceutical's president, Lan Wujun, emphasized the company's commitment to scientific and data-driven approaches in developing modern traditional Chinese medicine products [1] - The company aims to develop safe, effective, and high-quality products while adhering to relevant regulations and project progress [1] Group 2: Research and Development - The complexity and professionalism of drug development were acknowledged, with an emphasis on understanding the progress of specific product applications [1] - The company plans to disclose significant advancements to investors through legal information channels at appropriate times [1]